Sponsors
The bill expands coverage options, subsidies, Medicare benefits, and market stabilization tools that could substantially improve access and reduce out‑of‑pocket burdens for many, but it raises federal spending, creates implementation and oversight risks, and may shift costs or increase premiums for some groups.
Medicare beneficiaries and people aged 50–64 who qualify gain expanded benefits and enrollment options (hearing, dental, vision, guaranteed supplemental plans, a 50–64 buy‑in, premium assistance grants, and access to Medicare Ombudsman), reducing out‑of‑pocket costs and improving access to outpatient and supplemental care.
People who buy Marketplace coverage (including some low‑ and moderate‑income households previously above the subsidy cap) will be eligible for premium tax credits above 400% FPL and see subsidies phased on a linear sliding scale, lowering monthly premiums and smoothing subsidy changes across income tiers.
Individual‑market stability measures (an 80% reinsurance payments program with a dedicated fund and reauthorizing risk‑corridor style protections) reduce insurers' exposure to very high claims, which can stabilize plan availability and slow premium growth in some states.
Taxpayers and the federal budget face higher spending pressure because expanded premium tax credits, Medicare benefit expansions, buy‑in transfers, grants, and reinsurance funding will increase federal outlays and could raise the deficit or require offsets (higher taxes or cuts elsewhere).
Some individuals may face higher premiums or out‑of‑pocket costs: 50–64 buy‑in enrollees must pay monthly premiums (which could be high if set to reflect Medicare per‑capita costs), community‑rating and late‑enrollment penalties could raise costs for healthier or delayed enrollees, and insurers may pass reinsurance or fee costs through to consumers.
Implementing new sliding‑scale subsidy rules, buy‑in mechanics, drug negotiation outcomes, reinsurance fees, and restored repeal provisions creates substantial administrative and regulatory complexity for IRS, HHS, states, insurers, and providers, risking transitional confusion and short‑term disruption.
Based on analysis of 10 sections of legislative text.
Removes the ACA 400% FPL cap for premium tax credits; creates a Medicare buy‑in for ages 50–64 and a federal supplemental option; enables Part D price negotiations; funds individual‑market reinsurance; repeals a reconciliation subtitle.
Introduced March 12, 2026 by S. Raja Krishnamoorthi · Last progress March 12, 2026
Removes the ACA’s 400% federal poverty level cap on premium tax credit eligibility, restructures the income-based premium contribution schedule, and expands federal roles in health coverage and drug pricing. It creates a Medicare buy‑in for people aged 50–64 (allowing pre‑65 enrollment with Part A/B/D benefits), a new federal direct supplemental Medicare option to cover cost‑sharing, and authorizes HHS to negotiate prices for Part D drugs. The bill also sets up a federal individual‑market reinsurance fund to help pay for very high‑cost cases, allows the Innovation Center to include buy‑in enrollees in demonstrations, and repeals a prior reconciliation subtitle. These changes are phased in over several years: the premium tax credit changes take effect for taxable years after 2026; the Medicare supplemental option and some months apply starting in 2027 with coverage in 2028; the buy‑in enrollment begins at least one year after enactment; Part D price negotiations first apply to 2029 plan years; and reinsurance payments are planned beginning for plan years starting in 2025. The bill creates new trust/fund accounts and directs HHS/CMS and Treasury to set premiums, payment rules, reporting, and administrative processes.